FDA approves IQOS reduced health risk claims

The US Food and Drug Administration (FDA) has approved Philip Morris’ request to market its heated tobacco product, IQOS, with claims that it reduces exposure to harmful chemicals. The FDA rejected a separate request to label IQOS as a ‘reduced risk’ product, stating that there was insufficient evidence for this second claim.

Source: https://www.medpagetoday.com/primarycare/smoking/87437